TORRANCE, Calif.--(BUSINESS WIRE)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for the development of stem cell technologies for regenerative medicine, today announced that they have successfully cultured Human Hair Follicles in their 3D Organelle culture system. The 3D Organelle Human Hair Follicle system enables one to grow and test active molecules for growth and proliferation of human hair follicles. This system has been tested and validated in screening compounds for hair follicle stem cell proliferation and studying toxicity of cosmeceutical and also pharmaceutical reagents.
The present invention relates to screening molecules for their growth and proliferation of Human Hair Follicle Stem Cells and also to test their toxicities on human hair follicle. This 3D Organelle Culture (HF36007-08) is available as a screening platform that Celprogen provides as a service to Cosmetic and Pharmaceutical industries. FolliStem and STEMC8007 were initially developed and validated on this platform.
About Celprogen Inc.
Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at http://www.celprogen.com.
